References in periodicals archive ?
Persons Reporting Prescriptions for 10 Leading Psychiatric Drugs (a) Drug Name Mechanism Rank (Brand Name) of Action 1 Sertraline hydrochlolride SSRI (Zoloft) antidepressant 2 Citalopram hydrobromide SSRI (Celexa) antidepressant 3 Alprazolam (Xanax) Benzodiazepine 4 Zolpidem tartrate (Ambien) Hypnotic 5 Fluoxetine hydrochloride SSRI (Prozac) antidepressant 6 Trazodone hydrochloride SARI (Desyrel) antidepressant 7 Clonazepam (Klonopin) Benzodiazepine 8 Lorazepam (Ativan) Benzodiazepine 9 Escitalopram oxalate SSRI (Lexapro) antidepressant 10 Duloxetine hydrochloride SNRI (Cymbalta) antidepressant Reported Use, Prescriptions per Rank No.
In 1985, zolpidem was the first imidazopyridine investigated for clinical use as a hypnotic.
The minimal impact of the major confounders that were controlled for in this study suggest it is unlikely that confounding of other inadequately assessed confounders could explain the high mortality rate seen with hypnotics.
Rates of new cancers were 35 percent higher among patients who were prescribed at least 132 hypnotic doses a year as compared with those who did not take the drugs.
BARCELONA -- Antidepressant use seems to potentiate the need for concomitant hypnotic medications for extended periods, despite national recommendations that the sleeping aids be prescribed for no more than 4 consecutive weeks, a large study in the United Kingdom has determined.
The sedative hypnotics can be helpful to patients but also quite damaging.
7) The National Heart, Lung and Blood Institute Working Group on Insomnia recommends the use of short-acting hypnotics for short-term management of insomnia, but does not differentiate between short-acting benzodiazepines and the newer hypnotics such as zolpidem and zaleplon.
Thus, for most cases it is reasonable to conclude that since the duration of symptoms is likely to exceed by some magnitude the recommended duration of drug therapy, hypnotics appear to be an unsuitable response to insomnia in later life.
A third cyclopyrrolone is eszopiclone (Lunesta) has been in use in Europe since 1992; the FDA approved its use as a hypnotic in 2005 in the United States.
Most subjects had tried at least once before to stop their taking of hypnotics, without success.
Regardless of whether a randomized trial ever actually demonstrates that hypnotics do not increase and perhaps even do protect against falling in the frail elderly, Dr.